Decision-making criteria in polygenic embryo screening: A survey of reproductive medicine physicians

Rémy A Furrer1, Aayushi Gandhi2, Dorit Barlevy3

  • 1Department of Neurosurgery, Massachusetts General Hospital, Boston, MA; Harvard Medical School, Boston, MA.

Insights

Reproductive endocrinologists show skepticism towards polygenic embryo screening (PES), prioritizing embryo ploidy and morphology over PES predictions. They are more inclined to use PES for medical conditions than traits, reflecting nuanced clinical considerations.

Area of Science:

  • Reproductive medicine and genetics.
  • Embryo screening technologies.
  • Clinical decision-making in assisted reproduction.

Background:

  • Polygenic embryo screening (PES) assesses embryos for genetic predispositions to complex conditions and traits.
  • The commercialization of PES positions Reproductive Endocrinologists & Infertility specialists (REIs) as key decision-makers.
  • Professional guidelines currently advise against the clinical use of PES due to its developmental stage.

Purpose of the Study:

  • To survey U.S. REIs on their perceptions and decision-making approaches regarding PES.
  • To understand how REIs would integrate PES into clinical scenarios.
  • To gauge REI perspectives on the utility and limitations of PES.

Main Methods:

  • A survey was administered to 152 U.S. REIs.
  • Respondents evaluated hypothetical scenarios involving PES for various conditions and traits.
  • REIs assessed criteria for determining condition severity and prioritized PES against embryo ploidy and morphology.

Main Results:

  • REIs were more likely to consider PES for medical conditions (e.g., 62% for cancer) than for traits (e.g., 0% for skin color).
  • Clinical burden (e.g., high mortality) was prioritized over contextual burden (e.g., lifestyle modifiability) when evaluating severity, though all criteria were deemed important.
  • In cases of conflict, PES was rarely preferred over ploidy (8%) or morphology (30%), though patient choice was supported in some scenarios.

Conclusions:

  • REIs exhibit skepticism regarding the current clinical utility of PES.
  • Decision-making around PES is influenced by complex, context-dependent factors.
  • Findings highlight the need for further research and policy development regarding PES in reproductive endocrinology.
Abstract

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Polygenic Traits01:18

Polygenic Traits

When more than one gene is responsible for a given phenotype, the trait is considered polygenic. Human height is a polygenic trait. Studies have uncovered hundreds of loci that influence height, and there are believed to be many more. Due to the high number of genes involved, as well as environmental and nutritional factors, height varies significantly within a given population. The distribution of height forms a bell-shaped curve, with relatively few individuals in the population at the...
The Ratio of X Chromosome to Autosomes02:45

The Ratio of X Chromosome to Autosomes

In most organisms, sex is determined by the ratio of X and Y chromosomes. However, in some organisms, such as Drosophila and C.elegans, sex is determined by the ratio of the number of X chromosomes to the number of sets of autosomes. The Y chromosome in Drosophila is active but does not determine sex. It contains genes responsible for the production of sperms in adult flies.  
Normal male Drosophila has a ratio of one X chromosome to two sets of autosomes. In contrast, normal female Drosophila...